MicroRNAs: Small regulators with a big impact on lipid metabolism

Journal of Lipid Research

Volumn 54, Issue 5, 2013, Pages 1159-1160

  Moore, Kathryn J ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; MICRORNA; MICRORNA 33; MIPOMERSEN; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG;

CHOLESTEROL TRANSPORT; EDITORIAL; FAMILIAL HYPERCHOLESTEROLEMIA; FATTY ACID OXIDATION; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE SILENCING; HOMEOSTASIS; HUMAN; HUMAN GENOME; LIPID HOMEOSTASIS; LIPID METABOLISM; LIPOPROTEIN METABOLISM; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RNA ANALYSIS; RNA SEQUENCE; RNA SPLICING; RNA TRANSCRIPTION;

CELL COMMUNICATION; GENOME, HUMAN; HUMANS; LIPID METABOLISM; MICRORNAS;

EID: 84876807440     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.E036954     Document Type: Editorial

References (12)

1. Dunham, I., A. Kundaje, S. F. Aldred, P. J. Collins, C. A. Davis, F. Doyle, C. B. Epstein, S. Frietze, J. Harrow, and R. Kaul, et al. 2012. An integrated encyclopedia of DNA elements in the human genome. Nature. 489 : 57-74.
2. Bartel, D. P. 2009. MicroRNAs: Target recognition and regulatory functions. Cell. 136 : 215-233.
3. Esau, C., S. Davis, S. F. Murray, X. X. Yu, S. K. Pandey, M. Pear, L. Watts, S. L. Booten, M. Graham, and R. McKay, et al. 2006. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 3 : 87-98.
4. Rayner, K. J., Y. Suarez, A. Davalos, S. Parathath, M. L. Fitzgerald, N. Tamehiro, E. A. Fisher, K. J. Moore, and C. Fernandez-Hernando. 2010. MiR-33 contributes to the regulation of cholesterol homeostasis. Science. 328 : 1570-1573.
5. Zernecke, A., K. Bidzhekov, H. Noels, E. Shagdarsuren, L. Gan, B. Denecke, M. Hristov, T. Koppel, M. N. Jahantigh, and E. Lutgens, et al. 2009. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci. Signal. 2 : Ra81.
6. Mitchell, P. S., R. K. Parkin, E. M. Kroh, B. R. Fritz, S. K. Wyman, E. L. Pogosova-Agadjanyan, A. Peterson, J. Noteboom, K. C. O'Briant, and A. Allen, et al. 2008. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. USA. 105 : 10513-10518.
7. Lawrie, C. H., S. Gal, H. M. Dunlop, B. Pushkaran, A. P. Liggins, K. Pulford, A. H. Banham, F. Pezzella, J. Boultwood, and J. S. Wainscoat, et al. 2008. Detection of elevated levels of tumourassociated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br. J. Haematol. 141 : 672-675.
8. Couzin, J. 2008. MicroRNAs make big impression in disease after disease. Science. 319 : 1782-1784.
9. Rayner, K. J., C. C. Esau, F. N. Hussain, A. L. McDaniel, S. M. Marshall, J. M. van Gils, T. D. Ray, F. J. Sheedy, L. Goedeke, and X. Liu, et al. 2011. Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature. 478 : 404-407.
10. Jopling, C. L., M. Yi, A. M. Lancaster, S. M. Lemon, and P. Sarnow. 2005. Modulation of hepatitis C virus RNA abundance by a liverspecific MicroRNA. Science. 309 : 1577-1581.
11. Rayner, K. J., C. Fernandez-Hernando, and K. J. Moore. 2012. MicroRNAs regulating lipid metabolism in atherogenesis. Thromb. Haemost. 107 : 642-647.
12. Gebhard, C., G. Huard, E. A. Kritikou, and J. C. Tardif. 2013. Apolipoprotein B antisense inhibition-update on mipomersen. Curr. Pharm. Des. Epub ahead of print.